In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Is Our Investment Getting Us the Health Results We're Paying For?

This article was originally published in RPM Report

Executive Summary

Pfizer CEO Jeff Kindler sees theenvironment for pharma continuing to evolve at a fast pace. In a broad, direct speech to the leading PBM trade group he notes that pharm companiesare habving to adapt to a new world in which they do not exclusively control the information about their products. The changes will force pharm to pursue new opportunites, such as product differentiation through clinical services.
Advertisement

Related Content

REMS 2.0: FDA Refining New Drug Safety Tools
REMS 2.0: FDA Refining New Drug Safety Tools
Advertisement
UsernamePublicRestriction

Register

PS080759

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel